Discover how SGLT-2 inhibitors improve survival and reduce cardiac and kidney risks in diabetic kidney transplant recipients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback